Bottom line
VGHCX vs HGHAX: the short answer
VGHCX (Vanguard Health Care Fund) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 77% by weight.
VGHCX is cheaper at 0.33% vs 1.33% — a difference of $100 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
VGHCX vs HGHAX side by side
| VGHCX | HGHAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Vanguard | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.33% | 1.33% |
| Annual cost per $10k | $33 | $133 |
| 10-yr cost on $10k (prospectus) | $418 | $2,063 |
| Max front load | 0% | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +17.3% | — |
| 5-yr return (annualized) | +6.6% | — |
| 10-yr return (annualized) | +7.7% | — |
| Best quarter | +16.8% | +20.9% |
| Worst quarter | −12.3% | −15.7% |
| Net assets (fund) | $38.2B | $772.2M |
| Number of holdings | 97 | 80 |
| Portfolio turnover | 47% | 49% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VGHCX | HGHAX | Difference |
|---|---|---|---|
| 2025 | +17.3% | +15.6% | +1.7% |
| 2024 | −1.6% | 0.0% | −1.6% |
| 2023 | +5.4% | +3.8% | +1.6% |
| 2022 | −1.1% | −11.7% | +10.7% |
| 2021 | +14.3% | +10.0% | +4.3% |
| 2020 | +12.6% | +22.6% | −10.0% |
| 2019 | +22.9% | +33.3% | −10.3% |
| 2018 | +1.2% | −3.0% | +4.1% |
Source: Fund prospectus bar charts
Holdings overlap
19 of VGHCX's top 25 holdings also appear in HGHAX's top 25.
| Holding | VGHCX | HGHAX |
|---|---|---|
| Eli Lilly & Co | 8.61% | 12.03% |
| Merck & Co Inc | 5.44% | 6.00% |
| Johnson & Johnson | 4.83% | 6.75% |
| UnitedHealth Group Inc | 4.05% | 4.74% |
| Gsk Plc | 3.00% | 1.17% |
| Edwards Lifesciences Corp | 2.56% | 2.48% |
| Intuitive Surgical Inc | 2.52% | 2.88% |
| CVS Health Corp | 2.52% | 2.84% |
| Cencora Inc | 2.47% | 2.46% |
| Vertex Pharmaceuticals Inc | 2.36% | 2.64% |
| AbbVie Inc | 2.30% | 4.21% |
| Danaher Corp | 2.18% | 2.57% |
| Regeneron Pharmaceuticals Inc | 2.14% | 2.02% |
| Elevance Health Inc | 1.83% | 3.00% |
| HCA Healthcare Inc | 1.68% | 1.88% |
Source: SEC Form N-PORT
VGHCX top 10
- Eli Lilly & Co — 8.61%
- Merck & Co Inc — 5.44%
- Johnson & Johnson — 4.83%
- AstraZeneca PLC — 4.59%
- UnitedHealth Group Inc — 4.05%
- Gsk Plc — 3.00%
- Edwards Lifesciences Corp — 2.56%
- Intuitive Surgical Inc — 2.52%
- CVS Health Corp — 2.52%
- Cencora Inc — 2.47%
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FAQ
What is the difference between VGHCX and HGHAX?
Which is cheaper, VGHCX or HGHAX?
Should I own both VGHCX and HGHAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.